These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34003238)

  • 21. USPSTF update on sexually transmitted infections.
    Campos-Outcalt D
    J Fam Pract; 2020 Dec; 69(10):514-517. PubMed ID: 33348347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Practice Guidelines for Colorectal Cancer Screening: New Recommendations and New Challenges.
    Ransohoff DF; Sox HC
    JAMA; 2016 Jun; 315(23):2529-31. PubMed ID: 27304798
    [No Abstract]   [Full Text] [Related]  

  • 23. The US Preventive Services Task Force Recommendation on Lung Cancer Screening.
    Squires BS; Levitin R; Grills IS
    JAMA; 2021 Aug; 326(5):440-441. PubMed ID: 34342624
    [No Abstract]   [Full Text] [Related]  

  • 24. The US Preventive Services Task Force Recommendation on Lung Cancer Screening-Reply.
    Barry MJ; Davidson K; Mangione CM
    JAMA; 2021 Aug; 326(5):441. PubMed ID: 34342622
    [No Abstract]   [Full Text] [Related]  

  • 25. A History of the United States Preventive Services Task Force: Its Expanding Authority and Need for Reform.
    Kapoor DA
    J Urol; 2018 Jan; 199(1):37-39. PubMed ID: 28827107
    [No Abstract]   [Full Text] [Related]  

  • 26. Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United States.
    Landy R; Cheung LC; Berg CD; Chaturvedi AK; Robbins HA; Katki HA
    Ann Intern Med; 2019 Sep; 171(5):384-386. PubMed ID: 31158854
    [No Abstract]   [Full Text] [Related]  

  • 27. Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.
    Gupta S; Lieberman D; Anderson JC; Burke CA; Dominitz JA; Kaltenbach T; Robertson DJ; Shaukat A; Syngal S; Rex DK
    Gastroenterology; 2020 Mar; 158(4):1131-1153.e5. PubMed ID: 32044092
    [No Abstract]   [Full Text] [Related]  

  • 28. New US Preventive Services Task Force Recommendations on Screening for Eating Disorders.
    Nagata JM; Golden NH
    JAMA Intern Med; 2022 May; 182(5):471-473. PubMed ID: 35289838
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening for COPD: Challenging the United Sates Preventive Services Task Force Recommendation.
    Celli B
    Chest; 2023 Mar; 163(3):481-483. PubMed ID: 36894260
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous development of colorectal cancer screening programs.
    Hoff G; Ursin G; Løberg M; de Lange T; Skovlund E; Holme Ø
    Acta Oncol; 2019 Jun; 58(6):822-823. PubMed ID: 30939973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

  • 32. New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough.
    Wroclawski ML
    Einstein (Sao Paulo); 2017; 15(3):7-10. PubMed ID: 29091165
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Penson DF
    J Urol; 2016 Apr; 195(4 Pt 1):928-9. PubMed ID: 27302784
    [No Abstract]   [Full Text] [Related]  

  • 34. The United States Preventive Services Task Force recommendations for lung cancer screening.
    Blackmon SH; Feinglass SR
    Thorac Surg Clin; 2015 May; 25(2):199-203. PubMed ID: 25901563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: Turini et al.: The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement (Urology 2017;104:122-130).
    de Riese W; Verlage K; Grand R; de Riese CS; Cammack JT
    Urology; 2018 Apr; 114():246. PubMed ID: 28554516
    [No Abstract]   [Full Text] [Related]  

  • 36. Multilevel Small-Area Estimation of Colorectal Cancer Screening in the United States.
    Berkowitz Z; Zhang X; Richards TB; Nadel M; Peipins LA; Holt J
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):245-253. PubMed ID: 29500250
    [No Abstract]   [Full Text] [Related]  

  • 37. Consistency and sources of divergence in recommendations on screening with questionnaires for presently experienced health problems or symptoms: a comparison of recommendations from the Canadian Task Force on Preventive Health Care, UK National Screening Committee, and US Preventive Services Task Force.
    Thombs BD; Saadat N; Riehm KE; Karter JM; Vaswani A; Andrews BK; Simons P; Cosgrove L
    BMC Med; 2017 Aug; 15(1):150. PubMed ID: 28789659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reframing the US Preventive Services Task Force recommendations on screening for glaucoma.
    Parrish RK
    Am J Ophthalmol; 2014 Nov; 158(5):860-2. PubMed ID: 25437830
    [No Abstract]   [Full Text] [Related]  

  • 39. Ascertaining Costs and Benefits of Colonoscopy More Difficult Than the Procedure Itself.
    Cannon MF
    JAMA Intern Med; 2016 Aug; 176(8):1055-6. PubMed ID: 27304205
    [No Abstract]   [Full Text] [Related]  

  • 40. Updated recommendations for client- and provider-oriented interventions to increase breast, cervical, and colorectal cancer screening.
    Community Preventive Services Task Force
    Am J Prev Med; 2012 Jul; 43(1):92-6. PubMed ID: 22704753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.